Buamina Maitusong1, Xiang Xie1, Yi-Tong Ma2, Zhen-Yan Fu2, Yi-Ning Yang2, Xiao-Mei Li2, Fen Liu3, Bang-Dang Chen3, Min-Tao Gai3. 1. Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University Urumqi 830054, People's Republic of China. 2. Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University Urumqi 830054, People's Republic of China ; Xinjiang Key Laboratory of Cardiovascular Disease Research Urumqi 830054, People's Republic of China. 3. Xinjiang Key Laboratory of Cardiovascular Disease Research Urumqi 830054, People's Republic of China.
Abstract
BACKGROUND: ErbB3 is a member of the epidermal growth factor receptor (EGFR/ERBB) family of receptor tyrosine kinases. Recent research has shown that amplification of this gene is related to prostate, bladder and breast cancers, as well as low-density lipoprotein cholesterol (LDL-C) metabolism. LDL-C plays a considerable role in the development of cardiovascular disease. Thus, the present study assessed the association between human ErbB3 gene polymorphisms and coronary artery disease (CAD) in Han and Uygur populationsin China. METHODS: We performed two independent case-control studies with a Han population (339 CAD patients and 395 control subjects) and a Uygur population (306 CAD patients and 325 control subjects). All of the CAD patients and controls were genotyped for the same three single nucleotide polymorphisms (rs877636, rs705708, and rs10783779) in the ErbB3 gene by real-time PCR. RESULTS: In the Han population, rs877636 polymorphisms were associated with CAD on the basis of the genotypes, dominant model, additive model, and allele frequency (for genotypes: P = 0.008; for dominant model: P = 0.003; for additive model: P = 0.004; for allele: P = 0.008), and these significant difference was retained (all P < 0.05) after adjusting for the major confounding factors. CONCLUSION: The CT genotype and C allele of rs877636 in the ErbB3 gene could be a genetic marker of CAD risk for the Han population in China.
BACKGROUND:ErbB3 is a member of the epidermal growth factor receptor (EGFR/ERBB) family of receptor tyrosine kinases. Recent research has shown that amplification of this gene is related to prostate, bladder and breast cancers, as well as low-density lipoprotein cholesterol (LDL-C) metabolism. LDL-C plays a considerable role in the development of cardiovascular disease. Thus, the present study assessed the association between humanErbB3 gene polymorphisms and coronary artery disease (CAD) in Han and Uygur populationsin China. METHODS: We performed two independent case-control studies with a Han population (339 CAD patients and 395 control subjects) and a Uygur population (306 CAD patients and 325 control subjects). All of the CAD patients and controls were genotyped for the same three single nucleotide polymorphisms (rs877636, rs705708, and rs10783779) in the ErbB3 gene by real-time PCR. RESULTS: In the Han population, rs877636 polymorphisms were associated with CAD on the basis of the genotypes, dominant model, additive model, and allele frequency (for genotypes: P = 0.008; for dominant model: P = 0.003; for additive model: P = 0.004; for allele: P = 0.008), and these significant difference was retained (all P < 0.05) after adjusting for the major confounding factors. CONCLUSION: The CT genotype and C allele of rs877636 in the ErbB3 gene could be a genetic marker of CAD risk for the Han population in China.
Authors: M Matsuda; B S Korn; R E Hammer; Y A Moon; R Komuro; J D Horton; J L Goldstein; M S Brown; I Shimomura Journal: Genes Dev Date: 2001-05-15 Impact factor: 11.361
Authors: Elena Franchi; Paolo Marino; Giuseppe G Biondi-Zoccai; Giuseppe De Luca; Corrado Vassanelli; Pierfrancesco Agostoni Journal: Curr Cardiol Rep Date: 2009-09 Impact factor: 2.931
Authors: H C McGill; C A McMahan; E E Herderick; R E Tracy; G T Malcom; A W Zieske; J P Strong Journal: Arterioscler Thromb Vasc Biol Date: 2000-03 Impact factor: 8.311
Authors: Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson Journal: Cell Metab Date: 2005-06 Impact factor: 27.287
Authors: T Soonthornthum; H Arias-Pulido; N Joste; L Lomo; C Muller; T Rutledge; C Verschraegen Journal: Ann Oncol Date: 2011-02-16 Impact factor: 32.976
Authors: Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Sassan Hafizi; David L Rainwater; Michael C Mahaney; John L VandeBerg; Laura A Cox Journal: J Lipid Res Date: 2013-04-17 Impact factor: 5.922
Authors: Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis Journal: Nat Genet Date: 2008-01-13 Impact factor: 38.330